Cognition Therapeutics (CGTX) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CGTX Stock Alerts $1.82 -0.01 (-0.55%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCognition Therapeutics (NASDAQ:CGTX) Given "Outperform" Rating at Oppenheimeramericanbankingnews.com - March 28 at 4:20 AMCognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 27 at 10:06 AMCognition Therapeutics (NASDAQ:CGTX) Rating Reiterated by Oppenheimermarketbeat.com - March 27 at 8:29 AMCognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Updateglobenewswire.com - March 26 at 7:00 AMA Preview Of Cognition Therapeutics's Earningsbenzinga.com - March 26 at 12:10 AMCognition Therapeutics (CGTX) to Release Quarterly Earnings on Tuesdayamericanbankingnews.com - March 19 at 2:28 AMCognition Therapeutics, Inc. (NASDAQ:CGTX) Sees Significant Increase in Short Interestmarketbeat.com - March 15 at 3:13 PMCognition Therapeutics to Report Fourth Quarter and Full Year 2023 Resultsglobenewswire.com - March 15 at 7:30 AMCognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stockglobenewswire.com - March 14 at 4:05 PMCognition Therapeutics Prices Public Offering Of About 6.57 Mln Shares At $1.75/shrmarkets.businessinsider.com - March 12 at 2:27 AMCognition Therapeutics announces pricing of stock offering to raise $11.5Mmsn.com - March 12 at 2:27 AMGiants GM Joe Schoen swings big in trade, blockbuster contract for Panthers pass rusher Brian Burns while losing Xavier McKinneymsn.com - March 11 at 9:26 PMCognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stockglobenewswire.com - March 11 at 8:16 PMCognition Therapeutics Announces Proposed Public Offering of Common Stockglobenewswire.com - March 11 at 4:05 PMCognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studiesfinance.yahoo.com - March 6 at 4:22 PMCognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer's Disease Studiesglobenewswire.com - March 6 at 7:30 AMCognition Therapeutics to Present at the TD Cowen Health Care Conferenceglobenewswire.com - February 26 at 7:30 AMAnalysts Are Bullish on These Healthcare Stocks: Olema Pharmaceuticals (OLMA), IDEAYA Biosciences (IDYA)markets.businessinsider.com - February 22 at 2:04 PMCognition Therapeutics, Inc.: New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812finanznachrichten.de - February 6 at 2:12 PMNew Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812finance.yahoo.com - February 6 at 9:11 AMStudy suggests how cognitive behavioral therapy changes brain activity in children with anxietymsn.com - February 1 at 9:10 PMHere's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situationfinance.yahoo.com - January 16 at 2:48 PMDigital CBT intervention reduces anxiety and improves quality of life for pulmonary fibrosis patientsmsn.com - January 8 at 8:06 AMCognition Therapeutics, Inc.: Cognition Therapeutics CEO Issues Letter to Shareholdersfinanznachrichten.de - January 4 at 11:21 AMCognition Therapeutics CEO Issues Letter to Shareholdersfinance.yahoo.com - January 4 at 11:21 AMCognition Therapeutics files to sell 6.03M shares for holdersmsn.com - December 29 at 6:13 PMCognition Therapeutics Inc CGTXmorningstar.com - November 22 at 9:26 AMCognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltensfinance.yahoo.com - November 16 at 10:15 AMCognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer's and Parkinson's Diseasesstockhouse.com - November 15 at 1:13 PMCognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseasesfinance.yahoo.com - November 15 at 8:13 AMCognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Diseasebenzinga.com - November 7 at 8:49 AMCognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Diseasefinance.yahoo.com - November 7 at 8:49 AMCognition Therapeutics Inc (CGTX) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 3 at 8:58 AMCognition Therapeutics GAAP EPS of $0.22 beats by $0.46msn.com - November 2 at 12:35 PMCognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 2 at 12:35 PMCognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTADfinance.yahoo.com - October 27 at 12:48 PMCognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at CTADstockhouse.com - October 24 at 7:49 PMCognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTADfinance.yahoo.com - October 24 at 7:49 PMCognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple CNS Indicationsfinance.yahoo.com - October 16 at 2:47 PMCognition Therapeutics Inc.thestreet.com - September 27 at 3:39 PMCognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMDfinance.yahoo.com - September 7 at 8:07 AMCognition Therapeutics Announces Participation in Upcoming September Conferencesfinance.yahoo.com - August 30 at 8:22 AMLadenburg Thalmann Maintains Cognition Therapeutics (CGTX) Buy Recommendationmsn.com - August 14 at 6:28 PMWill Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely?finance.yahoo.com - August 9 at 10:52 AMQ2 2023 Cognition Therapeutics Inc Earnings Callfinance.yahoo.com - August 9 at 1:17 AMCognition Therapeutics, Inc.: Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Updatefinanznachrichten.de - August 8 at 10:16 AMCognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - August 8 at 10:16 AMCognition Therapeutics's Earnings Outlookbenzinga.com - August 8 at 10:16 AMCognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - August 8 at 10:16 AMCognition Therapeutics to Report Second Quarter 2023 Results in Conference Call on Tuesday, August 8, 2023finance.yahoo.com - August 2 at 10:24 AM Get Cognition Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CGTX Media Mentions By Week CGTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGTX News Sentiment▼1.020.61▲Average Medical News Sentiment CGTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGTX Articles This Week▼81▲CGTX Articles Average Week Get Cognition Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Semper Paratus Acquisition News Today Tevogen Bio News Today Ikena Oncology News Today Aligos Therapeutics News Today Atara Biotherapeutics News Today Genenta Science News Today Passage Bio News Today Turnstone Biologics News Today Cidara Therapeutics News Today Instil Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGTX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.